Cerevel Therapeutics (CERE) News Today → The AI Defense Stock Set to Soar (From Behind the Markets) (Ad) Free CERE Stock Alerts $42.38 +0.02 (+0.05%) (As of 03/27/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineHudson Bay Capital Management LP Invests $1.09 Million in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)marketbeat.com - March 17 at 5:12 AMN Anthony Coles Sells 50,000 Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Stockinsidertrades.com - March 16 at 8:17 AMCERE Apr 2024 40.000 callfinance.yahoo.com - March 16 at 2:48 AMGraham Capital Management L.P. Raises Stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)marketbeat.com - March 15 at 5:22 AMCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Shares Sold by Polar Capital Holdings Plcmarketbeat.com - March 13 at 8:12 AMCantor Fitzgerald Research Analysts Lower Earnings Estimates for Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)marketbeat.com - March 11 at 1:29 AMCerevel Therapeutics: Hold Rating Amidst Pending AbbVie Acquisitionmarkets.businessinsider.com - March 7 at 7:06 AMAnalysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX) and Perspective Therapeutics (CATX)markets.businessinsider.com - March 6 at 4:05 PMCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Shares Bought by Adage Capital Partners GP L.L.C.marketbeat.com - March 6 at 8:18 AMCerevel Therapeutics: Parkinson's Could Be The Issueseekingalpha.com - March 6 at 7:20 AMLake Street Advisors Group LLC Acquires New Shares in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)marketbeat.com - March 5 at 3:14 PMCharles Schwab Investment Management Inc. Has $11.29 Million Position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)marketbeat.com - February 29 at 4:26 AMMaintaining Hold Rating Amid ABBV-CERE Deal Progress and Rising Operational Costsmarkets.businessinsider.com - February 28 at 2:01 PMWestfield Capital Management Co. LP Boosts Stock Position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)marketbeat.com - February 28 at 8:12 AMCitigroup Inc. Increases Stake in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)marketbeat.com - February 25 at 4:49 AMABBV Mar 2024 182.500 calluk.finance.yahoo.com - February 24 at 3:32 PMUS Politicians Raise Concerns Over Capital One-Discover Dealbloomberg.com - February 23 at 11:35 PM3M Healthcare Unit Solventum Joins $53 Billion US Corporate Bond Sales Spreeuk.finance.yahoo.com - February 23 at 1:34 PMAnalysts Offer Insights on Healthcare Companies: Intellia Therapeutics (NTLA) and Intra-Cellular Therapies (ITCI)markets.businessinsider.com - February 22 at 8:53 PMAbbVie Selling $15 Billion Bonds to Buy ImmunoGen, Cerevelfinance.yahoo.com - February 22 at 3:53 PMAbbVie eyes selling at least $13 bln of bonds to fund M&A, Bloomberg reportsreuters.com - February 21 at 11:21 PMAbbVie (ABBV) Announces Appointment of New CEO Robert Michaelfinance.yahoo.com - February 21 at 1:21 PMCerevel Therapeutics (NASDAQ:CERE) Sees Unusually-High Trading Volumemarketbeat.com - February 20 at 11:56 AMFmr LLC Increases Position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)marketbeat.com - February 20 at 7:30 AMWall Street Breakfast Podcast: OpenAI's Text-To-Video AI Modelseekingalpha.com - February 16 at 8:39 PMCerevel Therapeutics (NASDAQ:CERE) Price Target Raised to $45.00marketbeat.com - February 16 at 7:39 PMAnalysts Are Bullish on Top Healthcare Stocks: Corcept Therapeutics (CORT), Bio-Rad Laboratories (BIO)markets.businessinsider.com - February 16 at 10:38 AMCerevel Therapeutics (NASDAQ:CERE) Sets New 52-Week High at $43.59marketbeat.com - February 15 at 10:45 AMAnalysts’ Opinions Are Mixed on These Healthcare Stocks: SAGE Therapeutics (SAGE) and Roivant Sciences (ROIV)markets.businessinsider.com - February 14 at 3:27 PMCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Shares Acquired by Barclays PLCmarketbeat.com - February 13 at 4:29 AMAbbVie Cuts Its Guidance on ImmunoGen Dealmsn.com - February 12 at 1:43 PMCerevel Therapeutics (NASDAQ:CERE) Reaches New 52-Week High at $42.91marketbeat.com - February 9 at 3:57 PMAbbVie’s full year 2023 sees a 6.4% net revenue dropmsn.com - February 5 at 1:38 PMCerevel Therapeutics Holdings Inc (CERE)investing.com - February 3 at 3:02 PMAbbVie Reports Full-Year and Fourth-Quarter 2023 Financial Resultses-us.finanzas.yahoo.com - February 3 at 10:01 AMAbbVie 4Q Sales Lower as Humira Revenue Sinksmorningstar.com - February 3 at 5:00 AMAnalysts Offer Insights on Healthcare Companies: Nurix Therapeutics (NRIX) and Regeneron (REGN)markets.businessinsider.com - February 2 at 12:31 PMAnalysts Conflicted on These Healthcare Names: Karuna Therapeutics (KRTX) and Health Catalyst (HCAT)markets.businessinsider.com - January 26 at 10:35 AMTop Picks 2024- Celldex Therapeutics CLDXfinance.yahoo.com - January 24 at 11:10 PMAnalysts Offer Insights on Healthcare Companies: Sensus Healthcare (SRTS), Outlook Therapeutics (OTLK) and Leap Therapeutics (LPTX)markets.businessinsider.com - January 24 at 1:09 PMNeumora Therapeutics, Inc.: Neumora Therapeutics Appoints Kaya Pai Panandiker as Chief Commercial Officerfinanznachrichten.de - January 22 at 8:10 AMCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Shares Purchased by TD Asset Management Incmarketbeat.com - January 16 at 5:43 AMCramer names biopharma companies to watch as industry mergers start to pile upmsn.com - January 5 at 9:37 PMWhat's in store for biotech M&A and IPOs in 2024?msn.com - January 1 at 5:46 PMChief Medical Officer Ramiro Sanchez Sells 10,000 Shares of Cerevel Therapeutics Holdings Incfinance.yahoo.com - December 29 at 8:05 PMCerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Short Interest Down 48.4% in Decembermarketbeat.com - December 29 at 2:11 PMRamiro Sanchez Sells 10,000 Shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE) Stockmarketbeat.com - December 28 at 6:30 PMAnalysts Are Bullish on These Healthcare Stocks: Coherus Biosciences (CHRS), Oncternal Therapeutics (ONCT)markets.businessinsider.com - December 27 at 8:36 PMJefferies Downgrades Cerevel Therapeutics Holdings (CERE)msn.com - December 23 at 5:51 PMInsider Sell: Cerevel Therapeutics Holdings Inc's Chief Human Resources Officer Sells Company Sharesfinance.yahoo.com - December 23 at 12:58 AM Get Cerevel Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CERE and its competitors with MarketBeat's FREE daily newsletter. Email Address The Small Biotech with a BIG Cancer Solution (Ad)There's a new cancer treatment so precise, it's been called a "smart bomb." One that can deliver a toxic payload directly to tumors while bypassing healthy cells. Get the full story here >>> CERE Media Mentions By Week CERE Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CERE News Sentiment▼1.890.61▲Average Medical News Sentiment CERE News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CERE Articles This Week▼13▲CERE Articles Average Week Get Cerevel Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CERE and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Elanco Animal Health News Today Jazz Pharmaceuticals News Today Cytokinetics News Today Viking Therapeutics News Today Roivant Sciences News Today Apellis Pharmaceuticals News Today Ascendis Pharma A/S News Today Intra-Cellular Therapies News Today Ionis Pharmaceuticals News Today Legend Biotech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CERE) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerevel Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.